U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Domestic Violence Prevention Enhancement and Leadership Through Alliances (DELTA) III Program
Announcement Type: Continuation – Type 2
Funding Opportunity Number: CDC-RFA-CE09-901
Catalog of Federal Domestic Assistance Number: 93.136
Key Dates:
Application Deadline: November 3, 2008
Authority: 42 U.S.C. 10418; and Sections 317(k)(2) and 393 of the Public Health Service Act (42 U.S.C. Sections 247b(k)(2) and 280b-1a, as amended.
Background:
The magnitude of the public health problem of intimate partner violence (IPV) in the United States can be understood in terms of fatalities and assaults. The FBI (2006) Supplemental Homicide Reports indicate that in 2005 more than 1,500 women and men died at the hands of an intimate partner. Of these homicides, 1,181 or 79% were women. The IPV homicides represented 9% of all homicides in the United States, 33.3% of all female homicides, and 2.5% of all male homicides that year. In terms of nonfatal assaults, Tjaden and Thoennes (2000) estimate, based on data from the National Violence Against Women Survey, 25 million women and 7 million men have experienced an IPV assault at some point in their lives, where IPV assault includes physical assaults, rape and stalking behavior.
The long-term health impact of the Domestic Violence Prevention Enhancement and Leadership Through Alliances (DELTA) III Program is a reduction in the incidence (i.e., number of people experiencing first time perpetration or victimization) of IPV in communities that receive DELTA funding and support. The previous CDC DELTA Funding Opportunity Announcements (FOAs) (i.e., CE-02122 and CE-05039), supported planning and initial implementation and evaluation of a primary prevention framework that was integrated into local coordinated community response (CCR) models. Integral to this process was the building of capacity in comprehensive primary prevention program planning and evaluation using an empowerment evaluation approach.
Please see Attachment A for definitions that apply to this FOA.
Purpose:
The purpose of the DELTA III program is to integrate primary prevention principles, concepts and practices into local CCRs that address IPV, such that the incidence of IPV is reduced. Specifically, this program will:
· build grantee and CCR individual and organizational capacity as well as state-level prevention system capacity to evaluate, improve, and sustain IPV primary prevention strategies using an empowerment evaluation approach, and
· develop and implement a process evaluation, outcome evaluation, continuous quality improvement (CQI) and sustainability plan using an empowerment evaluation approach.
This program addresses the “Healthy People 2010” focus area(s) of Injury and Violence Prevention.
Measurable outcomes of the program will be in alignment with the following performance goal for the National Center for Injury Prevention and Control (NCIPC): Increase the capacity (as defined in Section I, Background) of injury prevention and control programs to address the prevention of injuries and violence.
This FOA is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm
Awardee activities:
a) Coordinate, implement and evaluate DELTA III programmatic activities that integrate primary prevention principles, concepts, practices and programming into local CCRs in order to address and reduce the incidence of IPV.
b) To ensure program success, provide dedicated leadership to the DELTA III program, particularly in the areas of state-wide and organizational capacity-building. Based on historical DELTA program specific data, DELTA III key leadership should maintain a high level of effort. Leadership is expected to participate in bi-weekly conference calls with key partners; as well as participate in two DELTA III grantee meetings during each budget period and one DELTA Learning Exchange in the first budget period.
c) Maintain strong collaborative working relationships with local CCRs to achieve the goals and objectives of the DELTA III Program in accordance with 45CFR 74.47, http://edocket.access.gpo.gov/cfr_2003/octqtr/45cfr74.47.htm.
d) Provide training and technical assistance to local CCRs for the purposes of strengthening primary prevention strategies and the evidence that supports the use of evaluated strategies. Suggested topics include: 1) primary prevention, 2) community organization, 3) CCR development and maintenance, 4) effective prevention programming, 5) strategic planning, 6) process and outcome evaluation, 7) continuous quality improvement (i.e., using evaluation data to improve or replace strategies that lack evidence supporting their ability to prevent IPV), and 8) sustainability.
e) Provide a summative evaluation identifying progress on local CCR prevention strategy outcomes.
f) Evaluate changes in individual and organization capacity within DELTA-supported CCRs utilizing the quantitative and objective instruments used to conduct baseline assessments of these types of capacity under FOA CE-05039.
g) For state and local level planning:
1. Maintain and build the individual prevention capacity for established partner groups (i.e., DELTA State Steering Committee (SSC) and local CCR) to participate in, and guide the development and implementation of, plans for i) process and outcome evaluation, ii) continuous quality improvement (CQI) and iii) sustainability related to planning efforts conducted under FOA CE-05039. 2. Ensure completion of components of Step 7 of Getting to Outcomes for the Primary Prevention of Intimate Partner and Sexual Violence (GTO IPV-SV) using an empowerment evaluation approach by the end of the project period. This includes:
o developing a process evaluation plan,
o developing data systems, and
o building state and local capacity to collect, utilize and report process evaluation data for the purposes of program improvement.
3. Ensure completion of components of Step 8 of GTO IPV-SV using an empowerment evaluation approach by the end of the project period. This includes:
o developing an outcome evaluation plan,
o developing data systems, and
o building state and local capacity to collect, utilize and report outcome evaluation data for the purposes of program improvement.
4. Ensure completion of components of Step 9 of GTO IPV-SV using an empowerment evaluation approach by the end of the project period. This includes:
o developing a continuous quality improvement plan,
o developing data systems, and
o building state and local capacity to engage in continuous quality improvement for the purposes of program improvement.
5. Ensure completion of components of Step 10 of GTO IPV-SV using an empowerment evaluation approach by the end of the project period. This includes creating a sustainability plan.
h) Implement state-level IPV prevention system capacity objectives identified in the state IPV Prevention Plan developed under FOA CE-05039, with appropriate involvement of the State Steering Committee.
i) Evaluate changes in the capacity of the state-level prevention system utilizing the instrument used to conduct a baseline assessment of the state-level prevention system under FOA CE-05039.
j) Compile and disseminate DELTA III program results, lessons learned, successes and challenges within their state and to national level partners via multiple mechanisms such as listservs, conference calls, grantee meetings, web conferences and conferences.
k) Ensure institutionalization of primary prevention principles, concepts, and practices within grantee’s organization beyond DELTA III personnel.
l) Evaluate changes in individual and organization capacity within the grantee’s organization utilizing the quantitative and objective instruments used to conduct baseline assessments of these types of capacity under FOA CE-05039.
m) Collaborate with two or three coalitions who are working towards a higher level of IPV primary prevention expertise that can be enhanced with the knowledge and skills of the grantees of this FOA. This collaboration will focus on preparing the coalitions to support primary prevention IPV work within the states and communities they serve.
In a cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant monitoring.
CDC activities:
Type of Award: Cooperative Agreement. CDC’s involvement in this program is listed in the Activities Section above.
Award Mechanism: US4 - Community-Based Primary Prevention Programs: Intimate Partner Violence.
Fiscal Year Funds: 2009.
Approximate Current Fiscal Year Funding: $3.9 million. (This amount is an estimate, and is subject to availability of funds).
Approximate Total Project Period Funding: $11.1 million. (This amount is an estimate, and is subject to availability of funds. This amount includes direct and indirect costs)
Approximate Number of Awards: 14
Approximate Average Award: $280,000. (This amount is for the first 12-month budget period, and includes both direct and indirect costs.)
Floor of Individual Award Range: $170,000. (CDC will not make an award smaller than the floor amount).
Ceiling of Individual Award Range: $420,000 (CDC will not make an award for larger than the ceiling amount.)
Anticipated Award Date: January 30, 2009.
Budget Period Length: 12 months.
Project Period Length: 3 years.
Throughout the project period, CDC’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government.
III.1. Eligible Applicants
Eligible applicants are limited to those organizations that are currently funded recipients under CDC-RFA-05039.
III.2. Cost Sharing or Matching
Cost sharing or matching funds are not required for this program.
III.3. Other
If a funding amount greater than the ceiling of the award range is requested, the application will be considered non-responsive and will not be entered into the review process. The applicant will be notified that the application did not meet the submission requirements.
Special Requirements:
If the application is incomplete or non-responsive to the special requirements listed in this section, it will not be entered into the review process. The applicant will be notified the application did not meet submission requirements.
IV.1. Address to Request Application Package
To apply for this funding opportunity use the application forms package posted in Grants.gov.
Electronic Submission:
Application must be submitted electronically by utilizing the forms and instructions posted for this FOA on www.Grants.gov, the official Federal agency wide E-grant Web site.
Registering your organization through www.Grants.gov is the first step in submitting applications online. Registration information is located in the “Get Registered” screen of www.Grants.gov.
Please visit www.Grants.gov at least 30 days prior to filing your application to familiarize yourself with the registration and submission processes. Under “Get Registered,” the one-time registration process will take three to five days to complete; however, as part of the Grants.gov registration process, registering your organization with the Central Contractor Registry (CCR) annually, could take an additional one to two days to complete. We suggest submitting electronic applications prior to the closing date so if difficulties are encountered, you can submit a hard copy of the application prior to the deadline.
IV.2. Content and Form of Submission
Letter of Intent (LOI):
A letter of intent is not applicable to this FOA.
Application:
A project narrative must be submitted with the application forms. All electronic narratives must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format, if submitting a paper application:
The narrative should address activities to be conducted over the entire three year project period and must include the following items in the order listed:
Note: The narrative that accompanies each logic model should elaborate and clarify the timelines, inputs, activities, outputs, outcomes, and performance measures of effectiveness listed in the logic model diagram as well as describe key influential factors that are beyond the applicant’s control but may affect the applicant’s ability to meet its performance measures. Each logic model should have the appropriate objectives and quantitative performance measures of effectiveness for those objectives that build upon the work in the previous FOA CE-05039, and that will be used to measure the intended short-term and intermediate outcomes (i.e., capacity building) over the program period.
Additional information may be included in the application appendices. The appendices will not be counted toward the narrative page limit. This additional information includes:
· Appendix A: Letters of commitment from each local CCR. Letters should acknowledge that 1) one key performance objective for their CCR over the project period will be to evaluate and strengthen their IPV primary prevention strategies utilizing evaluation and other available evidence, 2) the applicant organization, as part of its monitoring responsibilities, may require CCRs to modify or replace a strategy when sufficient evidence has not been provided to suggest its ability to produce positive outcomes for the prevention of IPV; and 3) they will provide a travel budget for three representatives to attend the three-day DELTA Learning Exchange in Atlanta, Georgia in the first budget period.
· Appendix B: Copy of IRS determination letter.
Additional information submitted via Grants.gov should be uploaded in a PDF file format, and should be named:
No more than 10 electronic attachments should be uploaded per application.
The agency or organization is required to have a Dun and Bradstreet Data Universal Numbering System (DUNS) number to apply for a grant or cooperative agreement from the Federal government. The DUNS number is a nine-digit identification number, which uniquely identifies business entities. Obtaining a DUNS number is easy and there is no charge. To obtain a DUNS number, access the Dun and Bradstreet website or call 1-866-705-5711.
Application Deadline Date: November 3, 2008
Explanation of Deadlines: Applications must be received in the CDC Procurement and Grants Office by 5:00 p.m. Eastern Time on the deadline date.
Applications must be submitted electronically at www.Grants.gov. Applications completed on-line through Grants.gov are considered formally submitted when the applicant organization’s Authorizing Organization Representative (AOR) electronically submits the application to www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been successfully submitted electronically by the applicant organization’s AOR to Grants.gov on or before the deadline date and time.
When submission of the application is done electronically through Grants.gov (http://www.grants.gov), the application will be electronically time/date stamped and a tracking number will be assigned, which will serve as receipt of submission. The AOR will receive an e-mail notice of receipt when HHS/CDC receives the application.
This FOA is the definitive guide on application content, submission address, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline above, it will not be eligible for review. The application face page will be returned by HHS/CDC with a written explanation of the reason for non-acceptance. The applicant will be notified the application did not meet the submission requirements.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing the budget, are as follows:
If requesting indirect costs in the budget, a copy of the indirect cost rate agreement is required. If the indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. The indirect cost rate agreement should be uploaded as a PDF file with “Other Attachment Forms” when submitting via Grants.gov.
The recommended guidance for completing a detailed justified budget can be found on the CDC Web site, at the following Internet address:
http://www.cdc.gov/od/pgo/funding/budgetguide.htm.
IV.6. Other Submission Requirements
A letter of intent is not applicable to this FOA.
Application Submission Address:
Electronic Submission:
Applications must be submitted electronically at www.Grants.gov. The application package can be downloaded from www.Grants.gov. Applicants are able to complete it off-line, and then upload and submit the application via the Grants.gov Web site. E-mail submissions will not be accepted. If the applicant has technical difficulties in Grants.gov, customer service can be reached by E-mail at support@grants.gov or by phone at 1-800-518-4726 (1-800-518-GRANTS). The Customer Support Center is open from 7:00a.m. to 9:00p.m. Eastern Time, Monday through Friday.
HHS/CDC recommends that submittal of the application to Grants.gov should be prior to the closing date to resolve any unanticipated difficulties prior to the deadline.
The applicant must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov Web site. Use of file formats other than PDF may result in the file being unreadable by staff.
V.1. Criteria
Applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the cooperative agreement. Measures of effectiveness must relate to the performance goal stated in the “Purpose” section of this FOA. Measures must be objective and quantitative and must measure the intended outcomes: increased individual and organizational prevention capacity within grantee’s organization and CCRs that receive DELTA funding as well as increased state-level prevention system capacity. For individual and organizational prevention capacity and state-level prevention system capacity, applicants are expected to assess changes utilizing the same instruments used to assess baseline individual and organizational prevention capacity and their state-level prevention system under FOA CE-05039. Measures of effectiveness must be submitted with the application and will be an element of evaluation.
The application will be evaluated against the following criteria:
a. EXPERIENCE (30 POINTS)
The applicant demonstrates experience
· providing leadership in integrating primary prevention principles, concepts, practices and programming into local CCRs to address the incidence of IPV;
· facilitating a State Steering Committee through a comprehensive IPV prevention planning process using an empowerment evaluation approach;
· using GTO IPV-SV to guide their planning processes;
· using an empowerment evaluation approach to capacity building;
· conducting an in-depth multi-dimensional state-level assessment of intimate partner violence prevention system capacity; and
· conducting individual and organizational level prevention capacity assessments at the organizational and local levels.
b. IMPLEMENTATION PLAN for DELTA III Program (70 POINTS): Criteria for the implementation plan are organized by local, state, organizational and national levels. However, the following criteria should be considered overall:
· The applicant should devote adequate staff time to coordinate, implement and evaluate the program; and provide leadership for DELTA within their own organization (10 points).
· Implementation plan for local level activities (25 points).
The applicant’s implementation plan for local level activities includes a logic model, timeline and narrative that
o addresses each of the activities to build capacity in local CCRs;
o includes two performance measures of effectiveness;
o addresses how they will meet the short-term and intermediate outcomes listed in the logic model;
o describes how they will monitor each CCR’s implementation and evaluation of prevention strategy’s to ensure that each prevention strategy has sufficient evidence to suggest that it will produce positive outcomes for the prevention of IPV; and
o if the applicant is implementing local program planning processes, includes how they will complete components of Steps 7-10 of GTO IPV-SV.
In addition, the applicant includes letters of commitment from local CCR members.
· Implementation plan for state level activities (20 points):
The applicant’s implementation plan for state level activities includes a logic model, timeline and narrative that
o addresses each of the activities to build capacity across the state;
o includes how they will complete components of Steps 7-10 of GTO IPV-SV;
o addresses how they will build the capacity of the state – level IPV prevention system based on areas of weaknesses indicated in an in-depth, multi-dimensional assessment;
o addresses how they will meet the short-term and intermediate outcomes listed in the logic model; and
o includes one performance measure of effectiveness.
· Implementation plan for organizational level activities (10 points):
The applicant’s implementation plan for organizational level activities includes a logic model, timeline and narrative that
o addresses each of the activities to build their own organizational capacity;
o addresses how they will meet the short-term and intermediate outcomes listed in the logic model; and
o includes two performance measures of effectiveness.
· National level commitment to participate (5 points):
The applicant includes a statement of commitment to collaborate with two to three coalitions who are working towards a higher level of IPV primary prevention expertise that can be enhanced with the knowledge and skills of the grantees of this FOA.
c. MEASURES OF EFFECTIVENESS (Required and reviewed, but not scored).
o The applicant provides measures of effectiveness, as described in this FOA, related to increasing the capacity of injury prevention and control programs to address the prevention of injuries and violence.
d. BUDGET (SF 424A) and BUDGET NARRATIVE (Required and reviewed, but not scored).
o The applicant provides a detailed budget with complete line item justification of all proposed costs consistent with the stated activities, funding restrictions, and the items listed in the budget justification section in the FOA.
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff, and for responsiveness jointly by National Center for Injury Prevention and Control (NCIPC) and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet submission requirements.
An objective review panel will evaluate complete and responsive applications according to the criteria listed in the “V.1. Criteria” section above. Objective reviewers will be federal employees who do not work within NCIPC and/or external experts with no conflict of interest regarding the outcome of the awarding process. Each complete and responsive application will have primary, secondary and tertiary reviewers. The objective review panel will meet to discuss and score each application based on the reviewers’ comments. Applications will be funded in order by score and rank determined by the review panel.
January 1, 2009
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and emailed to the program director and a hard copy mailed to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of the application review by mail.
VI.2. Administrative and National Policy Requirements
Activities
Additional information on the requirements can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/Addtl_Reqmnts.htm.
CDC Assurances and Certifications can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/foamain.shtm
For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html
VI.3. Reporting Requirements
The applicant must provide CDC with an annual interim progress report via www.grants.gov:
1. The interim progress report is due no less than 120 days before the end of the budget period. The progress report will serve as the non-competing continuation application, and must contain the following elements:
a. Standard Form (“SF”) 424S Form.
b. SF-424A Budget Information-Non-Construction Programs.
c. Budget Narrative.
d. Indirect Cost Rate Agreement.
e. Project Narrative.
Additionally, the applicant must provide CDC with an original, plus two hard copies of the following reports:
2. Annual progress report, due 90 days after the end of the budget period. The annual progress report should include the status of the budget period activities.
3. Financial status report no more than 90 days after the end of the budget period.
These reports must be submitted to the attention of the Grants Management Specialist listed in the “VII. Agency Contacts” section of this announcement.
CDC encourages inquiries concerning this announcement.
For general questions, contact:
CDC Procurement and Grants Office
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700
For program technical assistance, contact:
Sandra Cashman, Project Officer
4770 Buford Highway, Mailstop F-63
Atlanta, GA 30341
Telephone: 770-488-1356
E-mail: scashman@cdc.gov
For financial, grants management, or budget assistance, contact:
Gladys Gissentanna, Grants Management Specialist
CDC Procurement and Grants Office
2920 Brandywine Road, MS K-70
Telephone: 770-488-2741
E-mail: ggissentanna@cdc.gov
CDC Telecommunications for the hearing impaired or disabled is available at: TTY 770-488-2783.
VIII. Other Information
Other CDC FOAs can be found on the CDC Web site, Internet address: http://www.cdc.gov/od/pgo/funding/FOAs.htm.
Applicants may access the application process and other awarding documents using the Electronic Research Administration System (eRA Commons). A one-time registration is required for interested institutions/organizations at http://era.nih.gov/ElectronicReceipt/preparing.htm
Program Directors/Principal Investigators (PD/PIs) should work with their institutions/organizations to make sure they are registered in the eRA Commons.
1. Organizational/Institutional Registration in the eRA Commons
· To find out if an organization is already eRA Commons-registered, see the "List of Grantee Organizations Registered in eRA Commons.”
·
Direct questions regarding the eRA Commons registration to:
eRA Commons Help Desk
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Business hours M-F 7:00 a.m. – 8:00 p.m. Eastern Time
Email
commons@od.nih.gov
2. Project Director/Principal Investigator (PD/PI) Registration in the eRA Commons: Refer to the NIH eRA Commons System (COM) Users Guide.
· The individual designated as the PD/PI on the application must also be registered in the eRA Commons. It is not necessary for PDs/PIs to register with Grants.gov.
· The PD/PI must hold a PD/PI account in the eRA Commons and must be affiliated with the applicant organization. This account cannot have any other role attached to it other than the PD/PI.
· This registration/affiliation must be done by the Authorized Organization Representative/Signing Official (AOR/SO) or their designee who is already registered in the eRA Commons.
· Both the PD/PI and AOR/SO need separate accounts in the eRA Commons since both hold different roles for authorization and to view the application process.
Note that if a PD/PI is also an HHS peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization. Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government.
Several of the steps of the registration process could take four weeks or more. Therefore, applicants should check with their business official to determine whether their organization/institution is already registered in the eRA Commons. HHS/CDC strongly encourages applicants to register to utilize these helpful on-line tools when applying for funding opportunities.
Attachment A
Definitions
For the purposes of this announcement, the following definitions apply:
Coordinated Community Responses (CCR): An organized effort, representing diverse service sectors and populations of a local community, to prevent and intervene in IPV. CCRs work to integrate prevention and intervention strategies and services through increased communications, cooperation, and coordination among participating service sectors and populations. A CCR must be an established legal entity that can accept and manage federal funds.
Empowerment Evaluation: An evaluation approach that aims to increase the probability of achieving strategy success by: (a) providing stakeholders with tools for assessing the planning, implementation, and self-evaluation of their strategy, and (b) mainstreaming evaluation as part of the planning and management of the organization (Adapted from Fetterman & Wandersman, 2007).
Getting to Outcomes for the Primary Prevention of Intimate Partner and Sexual Violence (GTO IPV-SV): GTO IPV-SV is a comprehensive needs and resources, planning, implementation and evaluation process for states and communities that promotes improvement and sustaining prevention strategies that show promise to prevent IPV and SV from initially occurring.
Intimate Partner Violence (IPV): IPV includes physical violence, sexual violence, threats of physical or sexual violence, psychological/emotional abuse and stalking. The types of intimate partnerships included are current spouses, former spouses, current non-marital partners, and former non-marital partner. There is no minimum time requirement for a relationship to be considered an intimate partner relationship as first dates and long-term boyfriend and girlfriend relationships are included under the term non-marital partners. Being an intimate partner does not require current cohabitation or sexual activities between two individuals. Intimate partners may also be of the same-sex or opposite sex. In addition, IPV exists on a continuum from episodic violence to battering. DELTA III seeks to address the entire continuum of IPV, not just the type of IPV referred to as battering.
Individual Prevention Capacity: The knowledge, skills, resources, and motivation necessary for an individual to implement strategies that are likely to lead to a reduction in incidence of IPV within the community they serve.
Organizational Prevention Capacity: The structures, processes, training and technical assistance activities, resources, and willingness necessary for an organization to promote an operating environment that supports the development and maintenance of programs, policies, procedures, strategies, activities, and resources that are likely to lead to a reduction in the incidence of IPV.
Prevention System Capacity: Characteristics such as leadership, strategic planning, information, community and constituency focus, human resources, systems operations, and results/outcomes documented that are necessary for a network of organizations and individuals, through their interaction, to support and expand the public health approach to preventing IPV and/ or SV. Intimate partner prevention system capacity refers to how well the system functions to achieve its identified purpose.
Primary Prevention: The DELTA III Program seeks to integrate primary prevention principles, concepts and practices into local CCRs that address IPV, such that the incidence of IPV is reduced. These principles, concepts and practices include the following:
CDC Home Page: http://www.cdc.gov
CDC Funding Web Page: http://www.cdc.gov/od/pgo/funding/FOAs.htm
CDC Forms Web Page: http://www.cdc.gov/od/pgo/funding/grants/app_and_forms.shtm